Skin-Specific CD301b+ Dermal Dendritic Cells Drive IL-17−Mediated Psoriasis-Like Immune Response in Mice
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 138 (4) , 844-853
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Ministry of Education (NRF-2014R1A4A1008625, NRF-2017R1D1A1B03035571)
- Ministry of Health and Welfare (HI17C1659)
This publication has 49 references indexed in Scilit:
- IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine ResponsesImmunity, 2013
- Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalkJournal of Clinical Investigation, 2012
- Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in miceJournal of Clinical Investigation, 2012
- GM-CSF Controls Nonlymphoid Tissue Dendritic Cell Homeostasis but Is Dispensable for the Differentiation of Inflammatory Dendritic CellsImmunity, 2012
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasisJournal of Allergy and Clinical Immunology, 2010
- Feedback control of regulatory T cell homeostasis by dendritic cells in vivoJournal of Experimental Medicine, 2009
- In Vivo Analysis of Dendritic Cell Development and HomeostasisScience, 2009
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic CellsJournal of Investigative Dermatology, 2009
- The Signal Transducer STAT5 Inhibits Plasmacytoid Dendritic Cell Development by Suppressing Transcription Factor IRF8Immunity, 2008